Cell Therapeutics Sued Over 'False' New Drug Filings
Biopharmaceutical company Cell Therapeutics Inc. and its executives have been hit with a putative class action accusing the drugmaker of misleading investors about testing and U.S. Food and Drug Administration fast-track...To view the full article, register now.
Already a subscriber? Click here to view full article